Toxicity of boehmite nanoparticles: Impact of the ultrafine fraction and of the agglomerates size on cytotoxicity and pro-inflammatory response

Inhalation Toxicology

Volumn 26, Issue 9, 2014, Pages 545-553

  Forest, Valérie ^a,b,c   Pailleux, Mélanie ^a,c,d   Pourchez, Jérémie ^a,b,c   Boudard, Delphine ^a,c,e,f,g   Tomatis, Maura ^h   Fubini, Bice ^h   Sennour, Mohamed ⁱ   Hochepied, Jean François ^i,j   Grosseau, Philippe ^d   Cottier, Michèle ^a,c,e,f,g  

^a Jean Monnet University   (France)

^b UMR CNRS 5148   (France)

^c SFR IFRESIS   (France)

^d ECOLE DES MINES DE SAINT ETIENNE   (France)

^e UNIVERSITÉ DE LYON   (France)

^f UNIVERSITÉ JEAN MONNET   (France)

^g UNIVERSITY HOSPITAL OF SAINT ETIENNE   (France)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ PSL RESEARCH UNIVERSITY   (France)

^j Ecole Nationale Superieure de Techniques Avancees   (France)

more..

Author keywords

Agglomerate size; Boehmite nanoparticles; Manufactured nanopowders; Toxicity; Ultrafine fraction

Indexed keywords

ALUMINUM OXIDE; METAL NANOPARTICLE; ALUMINUM HYDROXIDE; ALUMINUM OXIDE HYDROXIDE; NANOPARTICLE;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; IN VITRO STUDY; INFLAMMATION; MACROPHAGE; MORPHOLOGY; NANOFABRICATION; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICAL CHEMISTRY; POWDER; PRIORITY JOURNAL; RAT; SURFACE PROPERTY; ZETA POTENTIAL; ANIMAL; CELL LINE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MOUSE; TOXICITY; TOXICITY TESTING;

ALUMINUM HYDROXIDE; ALUMINUM OXIDE; ANIMALS; CELL LINE; INFLAMMATION; MACROPHAGES; MICE; NANOPARTICLES; OXIDATIVE STRESS; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; TOXICITY TESTS;

EID: 84904916606     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2014.925993     Document Type: Article

References (25)

1. Boczkowski J, Hoet P. (2010). What's new in nanotoxicology? Implications for public health from a brief review of the 2008 literature. Nanotoxicology 4:1-14.
2. Bonnefont-Rousselot D, Chantalat-Auger C, Teixeira A, et al. (2004). Blood oxidative stress status in patients with macrophagic myofasciitis. Biomed Pharmacother 58:516-19.
3. Bruch J, Rehn S, Rehn B, et al. (2004). Variation of biological responses to different respirable quartz flours determined by a vector model. Int J Hyg Environ Health 207:203-16.
4. Crisponi G, Nurchi VM, Bertolasi V, et al. (2012). Chelating agents for human diseases related to aluminum overload. Coord Chem Rev 256: 89-104.
5. Décret no 2012-232. (du 17 février 2012). relatif a la déclaration annuelle des substances a l'état nanoparticulaire pris en application de l'article L. 523-4 du code de l'environnement. Journal Officiel de la République Française.
6. De la Harpe J, Nathan CF. (1985). A semi-automated micro-assay for H2O2 release by human blood monocytes and mouse peritoneal macrophages. J Immunol Methods 78:323-36.
7. Fubini B, Fenoglio I, Ceschino R, et al. (2004). Relationship between the state of the surface of four commercial quartz flours and their biological activity in vitro and in vivo. Int J Hyg Environ Health 207:89-104.
8. Fubini B, Mollo L, Giamello E. (1995). Free radical generation at the solid/liquid interface in iron containing minerals. Free Radical Res 23: 593-614.
9. Fubini B, Ghiazza M, Fenoglio I. (2010). Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 4: 347-63.
10. Jiang J, Oberdörster G, Biswas P. (2009). Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J Nanopart Res 11:77-89.
11. Kuhlbusch TAJ, Krug HF, Nau K, et al. (2009). NanoCare: health related aspects of nanomaterials: final scientific report. Frankfurt: Dechema.
12. Leclerc L, Boudard D, Pourchez J, et al. (2010). Quantification of microsized fluorescent particles phagocytosis to a better knowledge of toxicity mechanisms. Inhal Toxicol 22:1091-100.
13. Magdolenova Z, Bilanicová D, Pojana G, et al. (2012). Impact of agglomeration and different dispersions of titanium dioxide nanoparticles on the human related in vitro cytotoxicity and genotoxicity. J Environ Monit 14:455-64.
14. Murdock RC, Braydich-Stolle L, Schrand AM, et al. (2008). Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol Sci 101:239-53.
15. Noël A, Maghni K, Cloutier Y, et al. (2012). Effects of inhaled nano- TiO(2) aerosols showing two distinct agglomeration states on rat lungs. Toxicol Lett 214:109-19.
16. Oberdörster G, Oberdörster E, Oberdörster J. (2005). Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-39.
17. OECD Environment, Health and Safety Publications Series on the Safety of Manufactured Nanomaterials (2008). ENV/JM/MONO(2008)13/REV.
18. Pauluhn J. (2009a). Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 109:152-67.
19. Pauluhn J. (2009b). Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): the key metric of dose is particle mass and not particle surface area. Toxicology 259:140-8.
20. Pauluhn J. (2011). Poorly soluble particulates: searching for a unifying denominator of nanoparticles and fine particles for DNEL estimation. Toxicology 279:176-88.
21. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)
22. Schneider T, Jensen KA. (2009). Relevance of aerosol dynamics and dustiness for personal exposure to manufactured nanoparticles. J Nanopart Res 11:1637-50.
23. Schrurs F, Lison D. (2012). Focusing the research efforts. Nat Nanotechnol 7:546-8.
24. Tsai CJ, Wu CH, Leu ML, et al. (2009). Dustiness test of nanopowders using a standard rotating drum with a modified sampling train. J Nanopart Res 11:121-31.
25. Wang W, Singh M. (2011). Selection of adjuvants for enhanced vaccine potency. World J Vaccines 1:33-78.